From TechCrunch · Lucas Ropek · · 1 min
Oura Files for IPO With $1.2B Revenue and Big AI Ambitions
Smart ring maker Oura is heading to Wall Street with soaring subscription revenue, a potential $16B valuation, and plans to expand into healthcare.
In brief
Smart ring maker Oura is heading to Wall Street with soaring subscription revenue, a potential $16B valuation, and plans to expand into healthcare. Oura's public filing highlights how wearable hardware coupled with recurring biometric subscriptions is evolving into a multi-billion-dollar health platform. Originally…
Oura files for public offering
Smart ring maker Oura has officially filed with the SEC to go public after revenue reached $1.2 billion for the nine-month period ending June 30. The company expects revenue to near $2 billion this year.
“The company went from $697 million in revenue during the nine-month period that ended June 30 last year to $1.2 billion during the corresponding period this year.”
Subscriptions power massive growth
Oura sold 3.6 million rings over the past year and boasts roughly 5 million paid subscribers. Its subscription service maintains an impressive 85% annual retention rate among members.
Targeting a $16 billion valuation
Reports indicate Oura is seeking to raise $3 billion in its initial public offering at a valuation around $16 billion, up significantly from its $11 billion valuation late last year.
Expanding beyond consumer fitness
Oura aims to extend its reach past consumer fitness tracking into clinical care, health plans, and enterprise wellness programs, marketing its hardware as an always-on health platform.
“We believe our platform can support significantly larger populations as we continue to expand access, build clinical evidence, and deepen integrations...”
Huge biometric dataset powers AI
With nearly 42 billion hours of physiological data collected across 50 metrics, Oura leverages its massive dataset to train machine-learning models that decode health patterns for personalized insights.
Legal scrutiny surrounds sleep metrics
Amid its IPO push, Oura faces a proposed class action lawsuit alleging its sleep-stage tracking is inaccurate and relies on estimates no better than a coin flip. Oura denies the allegations.
The short version
Oura's public filing highlights how wearable hardware coupled with recurring biometric subscriptions is evolving into a multi-billion-dollar health platform.






